Cytokinetics, Incorporated (CYTK)
CYTK price $63.72 +0.85 +1.36%
- Ticker
- CYTK
- Price
- $63.72
- Change
- +0.85 +1.36%
- Market cap
- $8.86B
- P/E
- -8.72
- Forward P/E
- 87.40
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule…